Use of ultra-rapid insulin with automated insulin delivery improves glycemic outcomes

Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had improvements in time in range and other continuous glucose monitoring metrics, according to study data. In a single-arm clinical trial published in Diabetes Technology & Therapeutics, researchers assessed glycemic outcomes for people with type 1 diabetes using ultra-rapid